rdf:type |
|
lifeskim:mentions |
umls-concept:C0023434,
umls-concept:C0024264,
umls-concept:C0035647,
umls-concept:C0599896,
umls-concept:C0887808,
umls-concept:C1314939,
umls-concept:C1441414,
umls-concept:C1514475,
umls-concept:C1553874,
umls-concept:C1578820,
umls-concept:C1880945
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-3-19
|
pubmed:abstractText |
Human cancer is characterized by complex molecular perturbations leading to variable clinical behavior, often even in single-disease entities. We performed a feasibility study systematically comparing large-scale gene expression profiles with clinical features in human B-cell chronic lymphocytic leukemia (B-CLL). cDNA microarrays were employed to determine the expression levels of 1,024 selected genes in 54 peripheral blood lymphocyte samples obtained from patients with B-CLL. Statistical analyses were applied to correlate the expression profiles with a number of clinical parameters including patient survival and disease staging. We were able to identify genes whose expression levels significantly correlated with patient survival and/or with clinical staging. Most of these genes code either for cell adhesion molecules (L-selectin, integrin-beta2) or for factors inducing cell adhesion molecules (IL-1beta, IL-8, EGR1), suggesting that prognosis of this disease may be related to a defect in lymphocyte trafficking. This report demonstrates the feasibility of a systematic integration of large-scale gene expression profiles with clinical data as a general approach for dissecting human diseases.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD18,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/EGR1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Early Growth Response Protein 1,
http://linkedlifedata.com/resource/pubmed/chemical/Immediate-Early Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8,
http://linkedlifedata.com/resource/pubmed/chemical/L-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/RNA,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0020-7136
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2001 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
474-80
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:11251968-Adult,
pubmed-meshheading:11251968-Aged,
pubmed-meshheading:11251968-Aged, 80 and over,
pubmed-meshheading:11251968-Antigens, CD18,
pubmed-meshheading:11251968-Cell Adhesion,
pubmed-meshheading:11251968-DNA, Complementary,
pubmed-meshheading:11251968-DNA-Binding Proteins,
pubmed-meshheading:11251968-Early Growth Response Protein 1,
pubmed-meshheading:11251968-Feasibility Studies,
pubmed-meshheading:11251968-Female,
pubmed-meshheading:11251968-Flow Cytometry,
pubmed-meshheading:11251968-Humans,
pubmed-meshheading:11251968-Immediate-Early Proteins,
pubmed-meshheading:11251968-Immunohistochemistry,
pubmed-meshheading:11251968-Immunophenotyping,
pubmed-meshheading:11251968-Interleukin-1,
pubmed-meshheading:11251968-Interleukin-8,
pubmed-meshheading:11251968-L-Selectin,
pubmed-meshheading:11251968-Leukemia, B-Cell,
pubmed-meshheading:11251968-Lymphocytes,
pubmed-meshheading:11251968-Male,
pubmed-meshheading:11251968-Middle Aged,
pubmed-meshheading:11251968-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:11251968-Plasmids,
pubmed-meshheading:11251968-Prognosis,
pubmed-meshheading:11251968-RNA,
pubmed-meshheading:11251968-Time Factors,
pubmed-meshheading:11251968-Transcription Factors
|
pubmed:year |
2001
|
pubmed:articleTitle |
CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking.
|
pubmed:affiliation |
Boehringer Ingelheim Austria, Exploratory Research, Dr. Boehringergasse 5-11, A-1121 Vienna, Austria. christian.stratowa@vie.boehringer-ingelheim.com
|
pubmed:publicationType |
Journal Article
|